Malaria drugs fail to help coronavirus patients in controlled studies
Hydroxychloroquine, the drug President Trump hailed as a coronavirus killer, had no beneficial effect for COVID-19 patients in two controlled trials.
Source: Los Angeles Times - Science - Category: Science Authors: Melissa Healy Source Type: news
More News: American Health | Coronavirus | COVID-19 | Hydroxychloroquine | Malaria | Science | Study | Trump | USA Health